Mankind Pharma
BSE: 543904 | NSE: MANKIND | ISIN: INE634S01028 | SECTOR:Open
2,374.75High
2,374.75Low
2,253.05Prev Close
2,333.00P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
911.64BVolume
32.23KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
2,297.35Ask
-
Company Description
BSE
543904NSE
MANKINDISIN
INE634S01028
Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.
Company Officers
Ramesh Juneja
Executive Chairman of the BoardPramod Gokhale
President, Group Chief Information OfficerSheetal Arora
Chief Executive Officer, Whole-Time DirectorRajeev Juneja
Executive Vice Chairman of the Board, Managing DirectorAshutosh Dhawan
Chief Financial OfficerBirendra Singh
President - Global Quality HeadAbhay Srivastava
President - OperationsFarhat Umar
President - Global Human ResourcesArjun Juneja
Chief Operating OfficerAtish Majumdar
Senior Vice President - Sales and Marketing